This index, validated in more than 2000 NAFLD patients using demographic data such as gender, age, and T2DM, anthropometric data such as HOMA, and biochemical values of glucose, insulin, AST, albumin, and platelets, effectively identified NAFLD patients with advanced fibrosis (108). Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.